Cipta Sarana Medika Tbk. vs Multikarya Asia Pasifik Raya Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Multikarya Asia Pasifik Raya Tbk. trades at Rp1,165 (market cap 3.79T, 336.3K 24h volume). The key difference: Multikarya Asia Pasifik Raya Tbk. is far larger — about 24× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 336.3K). Which is the better fit depends on your goals.
| DKHH | MKAP | |
|---|---|---|
Market Cap | 158.12B | 3.79T |
Volume | 8.21M | 336.3K |
Lot | 82.15K | 3.36K |
Turnover | 515.2M | 389.33M |
Average Price | 62.72 | 1,157.68 |
Value | 515.2M | 389.33M |
Indicative Equilibrium Price | 63 | 1,165 |
Indicative Equilibrium Volume | 1.33K | 2.5K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Multikarya Asia Pasifik Raya Tbk (the Company) was established on May 16, 2002 in Jakarta, Indonesia under the name of PT Mudking Asia Pasifik Raya, herein after, based on Notarial Deed No. 43 of Yunardi, S.H. The Company started its commercial operations in 2002.
Read more on MKAP →